论文部分内容阅读
目的:观察并探讨质子泵抑制剂联合血凝酶治疗消化性溃疡并出血的临床治疗效果。方法:选择我院2011年5月至2013年8月98例消化性溃疡并出血患者作为观察对象,随机将患者分为治疗组(49例)和对照组(49例)。治疗组给予质子泵抑制剂联合血凝酶进行治疗,对照组患者采用常规治疗方法,比较两组患者临床治疗效果。结果:治疗3d后,治疗组总有效率为95.9%,明显高于对照组(83.7%)。两组数据比较,差异具有统计学意义(P<0.05)。结论:质子泵抑制剂联合血凝酶治疗消化性溃疡并出血,治疗效果显著,值得临床推广。
Objective: To observe and discuss the clinical effect of proton pump inhibitor and hemagglutinase in the treatment of peptic ulcer and bleeding. Methods: A total of 98 patients with peptic ulcer and hemorrhage from May 2011 to August 2013 in our hospital were selected as observation subjects. Patients were randomly divided into treatment group (49 cases) and control group (49 cases). The treatment group was treated with proton pump inhibitor combined with hemagglutinin, and the control group patients were treated by conventional methods. The clinical effects of the two groups were compared. Results: After 3 days of treatment, the total effective rate in the treatment group was 95.9%, which was significantly higher than that in the control group (83.7%). The two groups of data, the difference was statistically significant (P <0.05). Conclusion: Proton pump inhibitor combined with hemagglutinin in the treatment of peptic ulcer bleeding, the treatment effect is significant, worthy of clinical promotion.